These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 12438255
1. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Takahashi M, Yang XJ, Lavery TT, Furge KA, Williams BO, Tretiakova M, Montag A, Vogelzang NJ, Re GG, Garvin AJ, Söderhäll S, Kagawa S, Hazel-Martin D, Nordenskjold A, Teh BT. Cancer Res; 2002 Nov 15; 62(22):6598-605. PubMed ID: 12438255 [Abstract] [Full Text] [Related]
2. Gene expression profiling of mesoblastic nephroma and Wilms tumors--comparison and clinical implications. Sugimura J, Yang XJ, Tretiakova MS, Takahashi M, Kort EJ, Fulton B, Fujioka T, Vogelzang NJ, Teh BT. Urology; 2004 Aug 15; 64(2):362-8; discussion 368. PubMed ID: 15302496 [Abstract] [Full Text] [Related]
3. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Takahashi M, Yang XJ, Sugimura J, Backdahl J, Tretiakova M, Qian CN, Gray SG, Knapp R, Anema J, Kahnoski R, Nicol D, Vogelzang NJ, Furge KA, Kanayama H, Kagawa S, Teh BT. Oncogene; 2003 Oct 02; 22(43):6810-8. PubMed ID: 14555994 [Abstract] [Full Text] [Related]
4. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker. Roberts DJ, Haber D, Sklar J, Crum CP. Lab Invest; 1993 May 02; 68(5):528-36. PubMed ID: 8388523 [Abstract] [Full Text] [Related]
5. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney. Yun K, Molenaar AJ, Fiedler AM, Mark AJ, Eccles MR, Becroft DM, Reeve AE. Lab Invest; 1993 Nov 02; 69(5):603-15. PubMed ID: 7504120 [Abstract] [Full Text] [Related]
6. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors. Granzen B, Efferth T, Keller U, Beniers AJ, Mertens R, Jakse G, Füzesi L. Anticancer Res; 2001 Nov 02; 21(1B):771-6. PubMed ID: 11299842 [Abstract] [Full Text] [Related]
8. Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour. Baudry D, Faussillon M, Cabanis MO, Rigolet M, Zucker JM, Patte C, Sarnacki S, Boccon-Gibod L, Junien C, Jeanpierre C. Oncogene; 2002 Aug 15; 21(36):5566-73. PubMed ID: 12165855 [Abstract] [Full Text] [Related]
9. Decrease in LDL receptor-related protein expression and function correlates with advanced stages of Wilms tumors. Desrosiers RR, Rivard ME, Grundy PE, Annabi B. Pediatr Blood Cancer; 2006 Jan 15; 46(1):40-9. PubMed ID: 16106426 [Abstract] [Full Text] [Related]
10. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors. Udtha M, Lee SJ, Alam R, Coombes K, Huff V. Oncogene; 2003 Jun 12; 22(24):3821-6. PubMed ID: 12802290 [Abstract] [Full Text] [Related]
11. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes. Fukuzawa R, Anaka MR, Heathcott RW, McNoe LA, Morison IM, Perlman EJ, Reeve AE. J Pathol; 2008 Aug 12; 215(4):377-87. PubMed ID: 18484682 [Abstract] [Full Text] [Related]
12. All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo. Zirn B, Samans B, Spangenberg C, Graf N, Eilers M, Gessler M. Oncogene; 2005 Aug 04; 24(33):5246-51. PubMed ID: 15897880 [Abstract] [Full Text] [Related]
14. Expression of apoptosis, cell proliferation, and drug resistance genes in pediatric Wilms' tumors. Ramachandran C, Melnick SJ, Escalon E, Jhabvala P, Khatib Z, Alamo A, Smith S. Anticancer Res; 2000 Aug 04; 20(5C):3759-65. PubMed ID: 11268451 [Abstract] [Full Text] [Related]
15. A gene expression signature for relapse of primary wilms tumors. Li W, Kessler P, Yeger H, Alami J, Reeve AE, Heathcott R, Skeen J, Williams BR. Cancer Res; 2005 Apr 01; 65(7):2592-601. PubMed ID: 15805255 [Abstract] [Full Text] [Related]
16. The expression of the insulin-like growth factor II, JIP-1 and WT1 genes in porcine nephroblastoma. Engström W, Granerus M. Anticancer Res; 2009 Dec 01; 29(12):4999-5003. PubMed ID: 20044608 [Abstract] [Full Text] [Related]
17. Clinical characteristics and outcome of Wilms tumors with a favorable histology in Japan: a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan. Suita S, Kinoshita Y, Tajiri T, Hara T, Tsuneyoshi M, Mizote H, Inada H, Takamatsu H, Kawano Y, Inomata Y, Nagasaki A, Ono Y, Handa N, Okamura J, Ishii E, Kawakami K, Committee for pediatric solid malignant tumors in the Kyushu area. J Pediatr Surg; 2006 Sep 01; 41(9):1501-5. PubMed ID: 16952581 [Abstract] [Full Text] [Related]
18. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor. Yun K, Fidler AE, Eccles MR, Reeve AE. Cancer Res; 1993 Nov 01; 53(21):5166-71. PubMed ID: 8221652 [Abstract] [Full Text] [Related]
19. Gene signatures of progression and metastasis in renal cell cancer. Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, Jonas D, Libermann TA. Clin Cancer Res; 2005 Aug 15; 11(16):5730-9. PubMed ID: 16115910 [Abstract] [Full Text] [Related]
20. Classification of malignant pediatric renal tumors by gene expression. Huang CC, Cutcliffe C, Coffin C, Sorensen PH, Beckwith JB, Perlman EJ, Renal Tumor Committee of the Children's Oncology Group. Pediatr Blood Cancer; 2006 Jun 15; 46(7):728-38. PubMed ID: 16425275 [Abstract] [Full Text] [Related] Page: [Next] [New Search]